[go: up one dir, main page]

AU1268192A - Cloning and expression of tissue transglutaminases - Google Patents

Cloning and expression of tissue transglutaminases

Info

Publication number
AU1268192A
AU1268192A AU12681/92A AU1268192A AU1268192A AU 1268192 A AU1268192 A AU 1268192A AU 12681/92 A AU12681/92 A AU 12681/92A AU 1268192 A AU1268192 A AU 1268192A AU 1268192 A AU1268192 A AU 1268192A
Authority
AU
Australia
Prior art keywords
cloning
expression
tissue transglutaminases
transglutaminases
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12681/92A
Inventor
Peter J. A Davies
Joseph P Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU1268192A publication Critical patent/AU1268192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU12681/92A 1991-01-04 1991-12-30 Cloning and expression of tissue transglutaminases Abandoned AU1268192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63575691A 1991-01-04 1991-01-04
US635756 1996-04-22

Publications (1)

Publication Number Publication Date
AU1268192A true AU1268192A (en) 1992-08-17

Family

ID=24548995

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12681/92A Abandoned AU1268192A (en) 1991-01-04 1991-12-30 Cloning and expression of tissue transglutaminases

Country Status (2)

Country Link
AU (1) AU1268192A (en)
WO (1) WO1992012238A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525335A (en) * 1992-04-21 1996-06-11 Ajinomoto Co., Inc. Wound healing agent
AU5590394A (en) * 1992-11-03 1994-05-24 Oklahoma Medical Research Foundation Transglutaminase gene
ES2101263T3 (en) * 1993-02-19 1997-07-01 Howard Green COMPOSITIONS CONTAINING CORNEOCYTE PROTEINS.
US5616500A (en) * 1993-04-30 1997-04-01 The United States Of America As Represented By The Department Of Health & Human Services Trichohyalin and transglutaminase-3 and methods of using same
US5549904A (en) * 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US6114119A (en) * 1997-08-29 2000-09-05 Wisconsin Alumni Research Foundation Transglutaminase and gene encoding same
US6190896B1 (en) 1997-11-14 2001-02-20 Bassam M. Fraij Active human cellular transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
WO1999036570A2 (en) 1998-01-20 1999-07-22 Pericor Science Inc Transglutaminase linkage of agents to tissue
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
CN1313396A (en) * 2000-03-10 2001-09-19 上海博德基因开发有限公司 Polypeptide-human transglutaminase 12 and polynucleotide for coding it
GB201209096D0 (en) 2012-05-24 2012-07-04 Medical Res Council Technology Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
ATE121776T1 (en) * 1986-09-19 1995-05-15 Zymogenetics Inc EXPRESSION OF BIOLOGICALLY ACTIVE FACTOR XIII.

Also Published As

Publication number Publication date
WO1992012238A1 (en) 1992-07-23

Similar Documents

Publication Publication Date Title
AU7435296A (en) Novel expression vectors and methods of use
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU4840293A (en) Cloning and expression of pur protein
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU7294194A (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
AU7130891A (en) Vectors and compounds for expression of zymogen forms of human protein c
AU2114792A (en) Win 49596-finasteride method of use and compositions
AU3428493A (en) Novel human transglutaminases
AU2749395A (en) Medical use of bromelain
AU1268192A (en) Cloning and expression of tissue transglutaminases
HU9600241D0 (en) Mutable composition and methods of use thereof
AU1753892A (en) Mammalian gap-43 compositions and methods of use
AU8074294A (en) Rapid synthesis and use of 18f-fluoromisonidazole and analogs
AU3325489A (en) N-alkoxyalkylamides of hydroxyacids and skin treating compositions therewith
AU7065694A (en) Catheter and method of use thereof
SG42309A1 (en) Medical use of enzymes
AU651992B2 (en) Polyethylene terephthalate compositions and methods of using thereof
AU8427091A (en) Gamma-carboxylase and methods of use
GB2294637B (en) Therapeutic compositions and methods of use
AU2148192A (en) Cloning and/or expression vectors, preparation and use
AU4709593A (en) Use of inhibitors of vacuolar-type H+ atpases
PL304896A1 (en) Cloning and expression of exo-polygalaktrurinase of aspergillus origin
AU2436095A (en) Cloning, expression, and uses of human lactoferrin
AU2831892A (en) Use of cosmetic composition
AU1880492A (en) Novel retro-alpha-retinol derivatives and uses of retro-alpha-retinol